[go: up one dir, main page]

YU394A - Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu - Google Patents

Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu

Info

Publication number
YU394A
YU394A YU394A YU394A YU394A YU 394 A YU394 A YU 394A YU 394 A YU394 A YU 394A YU 394 A YU394 A YU 394A YU 394 A YU394 A YU 394A
Authority
YU
Yugoslavia
Prior art keywords
phe
tic
tyr
procedures
act
Prior art date
Application number
YU394A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
P. Schiller
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of YU394A publication Critical patent/YU394A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
YU394A 1993-01-05 1994-01-05 Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu YU394A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300012A SE9300012D0 (sv) 1993-01-05 1993-01-05 New peptides

Publications (1)

Publication Number Publication Date
YU394A true YU394A (sh) 1997-07-31

Family

ID=20388466

Family Applications (1)

Application Number Title Priority Date Filing Date
YU394A YU394A (sh) 1993-01-05 1994-01-05 Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu

Country Status (25)

Country Link
US (1) US5602099A (sk)
EP (1) EP0678099A1 (sk)
JP (1) JPH08505386A (sk)
KR (1) KR960700269A (sk)
CN (1) CN1096515A (sk)
AP (1) AP508A (sk)
AU (1) AU681372B2 (sk)
CA (1) CA2152380A1 (sk)
CZ (1) CZ171195A3 (sk)
EE (1) EE9400326A (sk)
FI (1) FI953302A0 (sk)
HU (1) HUT72597A (sk)
IL (1) IL108169A0 (sk)
IS (1) IS4115A (sk)
LV (1) LV10962B (sk)
MX (1) MX9400255A (sk)
NO (1) NO952650L (sk)
NZ (1) NZ259597A (sk)
PL (1) PL309778A1 (sk)
SE (1) SE9300012D0 (sk)
SI (1) SI9400005A (sk)
SK (1) SK83995A3 (sk)
WO (1) WO1994015959A1 (sk)
YU (1) YU394A (sk)
ZA (1) ZA9455B (sk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683121B2 (en) * 1993-12-23 1997-10-30 Novo Nordisk A/S Compounds with growth hormone releasing properties
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
SE9503924D0 (sv) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
IL114046A0 (en) * 1994-06-20 1995-10-31 Astra Ab New opioid peptide antagonists
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
SE9402880D0 (sv) * 1994-08-30 1994-08-30 Astra Ab New peptide derivatives
US5780589A (en) * 1994-11-30 1998-07-14 The United States Of America As Represented By The Department Of Health And Human Services Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU708620B2 (en) * 1995-03-29 1999-08-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0837857A4 (en) * 1995-03-29 1998-08-05 Merck & Co Inc Inhibitors of farnesyl-protein transferase
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
SE9600769D0 (sv) * 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
US6703381B1 (en) 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US7601739B2 (en) 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
AU2005286733B2 (en) * 2004-09-23 2009-11-05 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP3160497A4 (en) * 2014-06-27 2018-01-17 H. Lee Moffitt Cancer Center And Research Institute, Inc. Conjugates for immunotherapy

Also Published As

Publication number Publication date
US5602099A (en) 1997-02-11
JPH08505386A (ja) 1996-06-11
NZ259597A (en) 1996-07-26
WO1994015959A1 (en) 1994-07-21
CZ171195A3 (en) 1996-09-11
IL108169A0 (en) 1994-04-12
FI953302L (fi) 1995-07-04
LV10962A (lv) 1995-12-20
HU9502041D0 (en) 1995-09-28
AU5844894A (en) 1994-08-15
PL309778A1 (en) 1995-11-13
HUT72597A (en) 1996-05-28
SI9400005A (en) 1994-12-31
NO952650D0 (no) 1995-07-04
FI953302A7 (fi) 1995-07-04
AU681372B2 (en) 1997-08-28
NO952650L (no) 1995-08-30
KR960700269A (ko) 1996-01-19
FI953302A0 (fi) 1995-07-04
EE9400326A (et) 1996-04-15
AP9400605A0 (en) 1994-01-31
MX9400255A (es) 1994-07-29
EP0678099A1 (en) 1995-10-25
SE9300012D0 (sv) 1993-01-05
CN1096515A (zh) 1994-12-21
AP508A (en) 1996-07-22
SK83995A3 (en) 1996-09-04
IS4115A (is) 1994-07-06
CA2152380A1 (en) 1994-07-21
ZA9455B (en) 1994-07-05
LV10962B (en) 1997-04-20

Similar Documents

Publication Publication Date Title
YU394A (sh) Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu
DE69226431D1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
YU54592A (sh) Hemijska jedinjenja
RU94042922A (ru) Новые соединения, способы их получения, фармацевтическая композиция
MXPA02006028A (es) Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
YU5396A (sh) Novi biološki aktivni proteini, njihove farmaceutske formulacije i postupak za njihovo dobijanje
BG66085B1 (bg) Фенилаланинови производни
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
IL232501A0 (en) Stable analogs of medicinal peptides and polypeptides
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
RU94044534A (ru) Амино-производные тиазола, способы их получения и содержащие их фармацевтические композиции
YU4197A (sh) Smeše koje se mogu izolovati polazeći od semena eugenia jambolana lamarck, njihovo dobijanje i primena ovih smeša i nekih od njihovih sastojaka kao lekova
DK1079849T3 (da) Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
YU15895A (sh) 5-vinil i 5-etinil-hinolon karbonske kiseline postupci za njihovo pripremanje kao i njihova upotreba za pripremanje lekova
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
BG101605A (bg) Ентерокинетични бензамиди
YU54692A (sh) Hemijska jedinjenja
GR3032950T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
MX9706927A (es) Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas.
YU76601A (sh) Novi kristalni oblici makrolidnog antibiotika
YU48997A (sh) Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides